SE444939B - Forfarande for framstellning av en antiallergiskt verksam blandning av 1,3-bis(2-karboxikromon-5-yloxi)propan-2-ol och antihistamin - Google Patents

Forfarande for framstellning av en antiallergiskt verksam blandning av 1,3-bis(2-karboxikromon-5-yloxi)propan-2-ol och antihistamin

Info

Publication number
SE444939B
SE444939B SE7803069A SE7803069A SE444939B SE 444939 B SE444939 B SE 444939B SE 7803069 A SE7803069 A SE 7803069A SE 7803069 A SE7803069 A SE 7803069A SE 444939 B SE444939 B SE 444939B
Authority
SE
Sweden
Prior art keywords
antihistamine
composition
yloxy
bis
propan
Prior art date
Application number
SE7803069A
Other languages
English (en)
Swedish (sv)
Other versions
SE7803069L (sv
Inventor
J Augstein
Altounyan R E Collingwood
T B Lee
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of SE7803069L publication Critical patent/SE7803069L/xx
Publication of SE444939B publication Critical patent/SE444939B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7803069A 1977-03-17 1978-03-16 Forfarande for framstellning av en antiallergiskt verksam blandning av 1,3-bis(2-karboxikromon-5-yloxi)propan-2-ol och antihistamin SE444939B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB11390/77A GB1582362A (en) 1977-03-17 1977-03-17 Cromoglycic acid salts and compositions

Publications (2)

Publication Number Publication Date
SE7803069L SE7803069L (sv) 1978-09-18
SE444939B true SE444939B (sv) 1986-05-20

Family

ID=9985349

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7803069A SE444939B (sv) 1977-03-17 1978-03-16 Forfarande for framstellning av en antiallergiskt verksam blandning av 1,3-bis(2-karboxikromon-5-yloxi)propan-2-ol och antihistamin

Country Status (18)

Country Link
JP (1) JPS53115823A (fr)
AU (1) AU516337B2 (fr)
BE (1) BE864837A (fr)
CA (1) CA1113862A (fr)
CH (1) CH628517A5 (fr)
DE (1) DE2810974A1 (fr)
DK (1) DK113378A (fr)
FI (1) FI780782A (fr)
FR (1) FR2383937A1 (fr)
GB (1) GB1582362A (fr)
IE (1) IE46581B1 (fr)
IL (1) IL54264A (fr)
LU (1) LU79253A1 (fr)
NL (1) NL7802869A (fr)
NO (1) NO152297C (fr)
NZ (1) NZ186712A (fr)
SE (1) SE444939B (fr)
ZA (1) ZA781520B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA812811B (en) * 1980-04-30 1982-06-30 Fisons Ltd Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
EP0040489A1 (fr) * 1980-05-17 1981-11-25 FISONS plc Mélanges, sels, emballages et compositions pharmaceutiques contenant l'acide 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyrane-2-carboxylique ou un de ses dérivés et une antihistamine antagoniste des récepteurs H2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them
FR2217004A1 (en) * 1973-02-15 1974-09-06 Aries Robert Sedatives and bronchodilatories - i.e. salts of 1,3-bis(2-carboxychromon-5-yloxy)propanes with 3-hydroxy-2-hydroxymethyl pyridines
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
DE2535258C2 (de) * 1974-08-10 1993-06-03 Fisons Plc, Ipswich, Suffolk Inhalierbares Medikament in Pelletform

Also Published As

Publication number Publication date
CH628517A5 (en) 1982-03-15
IE46581B1 (en) 1983-07-27
IL54264A (en) 1984-01-31
AU3427278A (en) 1979-09-20
NL7802869A (nl) 1978-09-19
JPS53115823A (en) 1978-10-09
ZA781520B (en) 1979-04-25
FR2383937B1 (fr) 1982-07-23
LU79253A1 (fr) 1978-10-17
SE7803069L (sv) 1978-09-18
NZ186712A (en) 1979-12-11
DE2810974A1 (de) 1978-09-21
CA1113862A (fr) 1981-12-08
IE780530L (en) 1978-09-17
NO780935L (no) 1978-09-19
BE864837A (fr) 1978-09-13
GB1582362A (en) 1981-01-07
AU516337B2 (en) 1981-05-28
NO152297C (no) 1985-09-04
FR2383937A1 (fr) 1978-10-13
DE2810974C2 (fr) 1988-07-21
FI780782A (fi) 1978-09-18
DK113378A (da) 1978-09-18
IL54264A0 (en) 1978-06-15
NO152297B (no) 1985-05-28

Similar Documents

Publication Publication Date Title
CA2822683C (fr) Compositions de bepostatine
ES2383433T3 (es) Formulación farmacéutica de apomorfina para administración bucal
US20110021786A1 (en) Pharmaceutical Solutions, Process of Preparation and Therapeutic Uses
JP7257371B2 (ja) 眼の病状の治療方法
JP2012520882A5 (fr)
JPS62178514A (ja) 眼局所投与用眼圧降下剤
JPH1160505A (ja) 防腐組成物
JP2020090547A (ja) 神経学的及び神経変性疾患及び障害を処置するための鼻腔投与組成物
RU2561871C2 (ru) Антагонист опиоидных рецепторов (налтрексон) для использования в терапии герпесного опоясывающего лишая
ES2246883T3 (es) Composicion para inhalacion que comprende delt-9-tetrahidrocanabidol en un disolvente semiacuoso.
WO2007023072A2 (fr) Utilisation d'ambroxol pour traiter les infections a rhinovirus
AU680539B2 (en) Use of ergoline derivatives for the treatment of glaucoma
KR20080053319A (ko) 브리부딘을 함유하는 헤르페스 각막염 치료용 광안정 약학조성물
HUE026162T2 (en) Olopatadine preparation for topical nasal administration
JPH11189533A (ja) 点眼薬
SE444939B (sv) Forfarande for framstellning av en antiallergiskt verksam blandning av 1,3-bis(2-karboxikromon-5-yloxi)propan-2-ol och antihistamin
JPH06500537A (ja) アテローム硬化症の治療のためのアリールヒドロキシ尿素化合物の使用
JP2019070026A (ja) 外用剤
JPS588013A (ja) 緑内障および高眼圧症の治療用薬学的調合物
JP2002308764A (ja) 眼科用医薬組成物
US4623664A (en) Oil suspended phenylephrine
SA90110074B1 (ar) تركيبات صيدلانية متضمنة على محلول مائي من مشتق بيرانوكوينولين pyranoquinoline
CA1110170A (fr) Composes hypotenseurs
CN101432000B (zh) 用于变应性眼病或变应性鼻病的包含三环性三唑并苯并氮杂*衍生物的预防剂或治疗剂
EP1137407B1 (fr) formulation ophtalmique comprenant un beta-bloquant et du carbopol

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7803069-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7803069-9

Format of ref document f/p: F